49
https://pubmed.ncbi.nlm.nih.gov/38116646
The study introduces Fe3O4@lapatinib-153Sm nanoparticles as a potential therapeutic agent for breast cancer, demonstrating high radiolabeling efficiency, desirable physicochemical properties, and favorable in vivo assessment in a murine model.
